Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events

Author:

Edsfeldt Andreas123ORCID,Singh Pratibha1,Matthes Frank1ORCID,Tengryd Christoffer1,Cavalera Michele1,Bengtsson Eva145,Dunér Pontus1,Volkov Petr67,Karadimou Glykeria8,Gisterå Anton9ORCID,Orho-Melander Marju1ORCID,Nilsson Jan1ORCID,Sun Jiangming1,Gonçalves Isabel13ORCID

Affiliation:

1. Department of Clinical Sciences, Malmö, Lund University , Lund , Sweden

2. Wallenberg Centre for Molecular Medicine, Lund University , Lund , Sweden

3. Department of Cardiology, Skåne University Hospital , Malmö , Sweden

4. Faculty of Health and Society, Malmö University , Malmö , Sweden

5. Biofilms—Research Center for Biointerfaces, Malmö University , Malmö , Sweden

6. Department of Clinical Sciences, LUDC Bioinformatics Unit, Malmö, Lund University , Lund , Sweden

7. Data Science and Quantitative Biology, Discovery Sciences, R&D, AstraZeneca , Gothenburg , Sweden

8. Department of Molecular Medicine and Surgery, Karolinska Institute , Stockholm , Sweden

9. Department of Medicine, Center for Molecular Medicine, Solna, Karolinska University Hospital, Karolinska Institutet , Stockholm , Sweden

Abstract

Abstract Aims Transforming growth factor-beta (TGF-β) exists in three isoforms TGF-β1, -β2, and -β3. TGF-β1 has been suggested to be important for maintaining plaque stability, yet the role of TGF-β2 and -β3 in atherosclerosis remains to be investigated. This study explores the association of the three isoforms of TGF-β with plaque stability in the human atherosclerotic disease. Methods and results TGF-β1, -β2, and -β3 proteins were quantified in 223 human carotid plaques by immunoassays. Indications for the endarterectomy were: symptomatic carotid plaque with stenosis >70% or without symptoms and >80% stenosis. Plaque mRNA levels were assessed by RNA sequencing. Plaque components and extracellular matrix were measured histologically and biochemically. Matrix metalloproteinases and monocyte chemoattractant protein-1 (MCP-1) was measured with immunoassays. The effect of TGF-β2 on inflammation and protease activity was investigated in vitro using THP-1 and RAW264.7 macrophages. Patients were followed longitudinally for cardiovascular (CV) events. TGF-β2 was the most abundant isoform and was increased at both protein and mRNA levels in asymptomatic plaques. TGF-β2 was the main determinant separating asymptomatic plaques in an Orthogonal Projections to Latent Structures Discriminant Analysis. TGF-β2 correlated positively to features of plaque stability and inversely to markers of plaque vulnerability. TGF-β2 was the only isoform inversely correlated to the matrix-degrading matrix metalloproteinase-9 and inflammation in the plaque tissue. In vitro, TGF-β2 pre-treatment reduced MCP-1 gene and protein levels as well as matrix metalloproteinase-9 gene levels and activity. Patients with plaques with high TGF-β2 levels had a lower risk to suffer from future CV events. Conclusions TGF-β2 is the most abundant TGF-β isoform in human plaques and may maintain plaque stability by decreasing inflammation and matrix degradation.

Funder

Swedish Research Council

Swedish Heart and Lung Foundation

Skåne University Hospital

Påhlsson Foundation

Crafoord Foundation

Swedish Society for Medical Research

Swedish Society of Medicine

Lund University Diabetes Centre

Knut and Alice Wallenberg Foundation

Medical Faculty of Lund University, and Region Skåne

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3